Genetic testing for hereditary breast and ovarian cancer (HBOC) is recommended for breast
cancer patients diagnosed at age≤ 50 years. Our objective was to examine racial/ethnic …

Purpose An estimated 10% of breast and ovarian cancers result from hereditary causes.
Current testing guidelines for germ line susceptibility genes in patients with breast …

Approximately 5% to 10% of women diagnosed with breast cancer will have a pathogenic
variant (PV) in a hereditary cancer susceptibility gene, and this has significant implications …

Importance The practice of genetic testing for hereditary breast and/or ovarian cancer
(HBOC) is rapidly evolving owing to the recent introduction of multigene panels. While these …

PURPOSE: To understand genetic testing use and decision making among patients with
high genetic risk. MATERIALS AND METHODS: A survey of breast cancer survivors was …

Purpose In the United States, 3.8 million women have a history of breast (BC) or ovarian
cancer (OC). Up to 15% of cases are attributable to heritable mutations, which, if identified …

Background Young women with breast cancer have an increased risk for harboring a
BRCA1 or BRCA2 mutation. Frequency of genetic testing and factors associated with testing …

Risk assessment coupled with genetic counseling and testing for the cancer predisposition
genes BRCA1 and BRCA2 (BRCA1/2) has become an integral element of comprehensive …

Abstract Background The Georgia Breast Cancer Genomic Health Consortium is a
partnership created with funding from the Centers for Disease Control and Prevention (CDC) …

Concerns about the potential for genomic advances to increase health disparities have been
raised. Thus, it is important to assess referral and uptake of genetic counseling (GC) and …